Report cover image

Global OTC Drug and Dietary Supplement Market Outlook and Growth Opportunities 2025

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 198 Pages
SKU # APRC20360432

Description

Summary

According to APO Research, the global OTC Drug and Dietary Supplement market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.

The North American market for OTC Drug and Dietary Supplement is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % from 2025 through 2031.

The Asia-Pacific market for OTC Drug and Dietary Supplement is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

In China, the OTC Drug and Dietary Supplement market is expected to rise from $ million to $ million by 2031, at a CAGR of I% from 2025 through 2031.

The Europe market for OTC Drug and Dietary Supplement is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Major global companies in the OTC Drug and Dietary Supplement market include Abbott, Pfizer, GSK, Bayer, Suntory, Reckitt Benckiser, Herbalife, Glanbia and Blackmores, etc. In 2024, the top three vendors accounted for approximately % of the market revenue.

This report presents an overview of global market for OTC Drug and Dietary Supplement, revenue and gross margin. Analyses of the global market trends, with historic market revenue for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of OTC Drug and Dietary Supplement, also provides the value of main regions and countries. Of the upcoming market potential for OTC Drug and Dietary Supplement, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the OTC Drug and Dietary Supplement revenue, market share and industry ranking of main companies, data from 2020 to 2025. Identification of the major stakeholders in the global OTC Drug and Dietary Supplement market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
All companies have demonstrated varying levels of sales growth and profitability over the past six years, while some companies have experienced consistent growth, others have shown fluctuations in performance. The overall trend suggests a positive outlook for the global OTC Drug and Dietary Supplement company landscape, with companies adapting to market dynamics and maintaining profitability amidst changing conditions.
OTC Drug and Dietary Supplement Segment by Company

Abbott
Pfizer
GSK
Bayer
Suntory
Reckitt Benckiser
Herbalife
Glanbia
Blackmores
Amway
OTC Drug and Dietary Supplement Segment by Type

Powders
Capsules
Tablets
Liquids
OTC Drug and Dietary Supplement Segment by Application

Convenience Stores
Supermarkets
Pharmacies
OTC Drug and Dietary Supplement Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global OTC Drug and Dietary Supplement status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the OTC Drug and Dietary Supplement key companies, revenue, market share, and recent developments.
3. To split the OTC Drug and Dietary Supplement breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions OTC Drug and Dietary Supplement market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify OTC Drug and Dietary Supplement significant trends, drivers, influence factors in global and regions.
6. To analyze OTC Drug and Dietary Supplement competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global OTC Drug and Dietary Supplement market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of OTC Drug and Dietary Supplement and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of OTC Drug and Dietary Supplement.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global OTC Drug and Dietary Supplement industry.
Chapter 3: Detailed analysis of OTC Drug and Dietary Supplement company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of OTC Drug and Dietary Supplement in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of OTC Drug and Dietary Supplement in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.

Table of Contents

198 Pages
1 Market Overview
1.1 Product Definition
1.2 Global OTC Drug and Dietary Supplement Market Size, 2020 VS 2024 VS 2031
1.3 Global OTC Drug and Dietary Supplement Market Size (2020-2031)
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 OTC Drug and Dietary Supplement Market Dynamics
2.1 OTC Drug and Dietary Supplement Industry Trends
2.2 OTC Drug and Dietary Supplement Industry Drivers
2.3 OTC Drug and Dietary Supplement Industry Opportunities and Challenges
2.4 OTC Drug and Dietary Supplement Industry Restraints
3 OTC Drug and Dietary Supplement Market by Company
3.1 Global OTC Drug and Dietary Supplement Company Revenue Ranking in 2024
3.2 Global OTC Drug and Dietary Supplement Revenue by Company (2020-2025)
3.3 Global OTC Drug and Dietary Supplement Company Ranking (2023-2025)
3.4 Global OTC Drug and Dietary Supplement Company Manufacturing Base and Headquarters
3.5 Global OTC Drug and Dietary Supplement Company Product Type and Application
3.6 Global OTC Drug and Dietary Supplement Company Establishment Date
3.7 Market Competitive Analysis
3.7.1 Global OTC Drug and Dietary Supplement Market Concentration Ratio (CR5 and HHI)
3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
3.7.3 2024 OTC Drug and Dietary Supplement Tier 1, Tier 2, and Tier 3 Companies
3.8 Mergers and Acquisitions Expansion
4 OTC Drug and Dietary Supplement Market by Type
4.1 OTC Drug and Dietary Supplement Type Introduction
4.1.1 Powders
4.1.2 Capsules
4.1.3 Tablets
4.1.4 Liquids
4.2 Global OTC Drug and Dietary Supplement Sales Value by Type
4.2.1 Global OTC Drug and Dietary Supplement Sales Value by Type (2020 VS 2024 VS 2031)
4.2.2 Global OTC Drug and Dietary Supplement Sales Value by Type (2020-2031)
4.2.3 Global OTC Drug and Dietary Supplement Sales Value Share by Type (2020-2031)
5 OTC Drug and Dietary Supplement Market by Application
5.1 OTC Drug and Dietary Supplement Application Introduction
5.1.1 Convenience Stores
5.1.2 Supermarkets
5.1.3 Pharmacies
5.2 Global OTC Drug and Dietary Supplement Sales Value by Application
5.2.1 Global OTC Drug and Dietary Supplement Sales Value by Application (2020 VS 2024 VS 2031)
5.2.2 Global OTC Drug and Dietary Supplement Sales Value by Application (2020-2031)
5.2.3 Global OTC Drug and Dietary Supplement Sales Value Share by Application (2020-2031)
6 OTC Drug and Dietary Supplement Regional Value Analysis
6.1 Global OTC Drug and Dietary Supplement Sales Value by Region: 2020 VS 2024 VS 2031
6.2 Global OTC Drug and Dietary Supplement Sales Value by Region (2020-2031)
6.2.1 Global OTC Drug and Dietary Supplement Sales Value by Region: 2020-2025
6.2.2 Global OTC Drug and Dietary Supplement Sales Value by Region (2026-2031)
6.3 North America
6.3.1 North America OTC Drug and Dietary Supplement Sales Value (2020-2031)
6.3.2 North America OTC Drug and Dietary Supplement Sales Value Share by Country, 2024 VS 2031
6.4 Europe
6.4.1 Europe OTC Drug and Dietary Supplement Sales Value (2020-2031)
6.4.2 Europe OTC Drug and Dietary Supplement Sales Value Share by Country, 2024 VS 2031
6.5 Asia-Pacific
6.5.1 Asia-Pacific OTC Drug and Dietary Supplement Sales Value (2020-2031)
6.5.2 Asia-Pacific OTC Drug and Dietary Supplement Sales Value Share by Country, 2024 VS 2031
6.6 South America
6.6.1 South America OTC Drug and Dietary Supplement Sales Value (2020-2031)
6.6.2 South America OTC Drug and Dietary Supplement Sales Value Share by Country, 2024 VS 2031
6.7 Middle East & Africa
6.7.1 Middle East & Africa OTC Drug and Dietary Supplement Sales Value (2020-2031)
6.7.2 Middle East & Africa OTC Drug and Dietary Supplement Sales Value Share by Country, 2024 VS 2031
7 OTC Drug and Dietary Supplement Country-level Value Analysis
7.1 Global OTC Drug and Dietary Supplement Sales Value by Country: 2020 VS 2024 VS 2031
7.2 Global OTC Drug and Dietary Supplement Sales Value by Country (2020-2031)
7.2.1 Global OTC Drug and Dietary Supplement Sales Value by Country (2020-2025)
7.2.2 Global OTC Drug and Dietary Supplement Sales Value by Country (2026-2031)
7.3 USA
7.3.1 USA OTC Drug and Dietary Supplement Sales Value Growth Rate (2020-2031)
7.3.2 USA OTC Drug and Dietary Supplement Sales Value Share by Type, 2024 VS 2031
7.3.3 USA OTC Drug and Dietary Supplement Sales Value Share by Application, 2024 VS 2031
7.4 Canada
7.4.1 Canada OTC Drug and Dietary Supplement Sales Value Growth Rate (2020-2031)
7.4.2 Canada OTC Drug and Dietary Supplement Sales Value Share by Type, 2024 VS 2031
7.4.3 Canada OTC Drug and Dietary Supplement Sales Value Share by Application, 2024 VS 2031
7.5 Mexico
7.5.1 Mexico OTC Drug and Dietary Supplement Sales Value Growth Rate (2020-2031)
7.5.2 Mexico OTC Drug and Dietary Supplement Sales Value Share by Type, 2024 VS 2031
7.5.3 Mexico OTC Drug and Dietary Supplement Sales Value Share by Application, 2024 VS 2031
7.6 Germany
7.6.1 Germany OTC Drug and Dietary Supplement Sales Value Growth Rate (2020-2031)
7.6.2 Germany OTC Drug and Dietary Supplement Sales Value Share by Type, 2024 VS 2031
7.6.3 Germany OTC Drug and Dietary Supplement Sales Value Share by Application, 2024 VS 2031
7.7 France
7.7.1 France OTC Drug and Dietary Supplement Sales Value Growth Rate (2020-2031)
7.7.2 France OTC Drug and Dietary Supplement Sales Value Share by Type, 2024 VS 2031
7.7.3 France OTC Drug and Dietary Supplement Sales Value Share by Application, 2024 VS 2031
7.8 U.K.
7.8.1 U.K. OTC Drug and Dietary Supplement Sales Value Growth Rate (2020-2031)
7.8.2 U.K. OTC Drug and Dietary Supplement Sales Value Share by Type, 2024 VS 2031
7.8.3 U.K. OTC Drug and Dietary Supplement Sales Value Share by Application, 2024 VS 2031
7.9 Italy
7.9.1 Italy OTC Drug and Dietary Supplement Sales Value Growth Rate (2020-2031)
7.9.2 Italy OTC Drug and Dietary Supplement Sales Value Share by Type, 2024 VS 2031
7.9.3 Italy OTC Drug and Dietary Supplement Sales Value Share by Application, 2024 VS 2031
7.10 Spain
7.10.1 Spain OTC Drug and Dietary Supplement Sales Value Growth Rate (2020-2031)
7.10.2 Spain OTC Drug and Dietary Supplement Sales Value Share by Type, 2024 VS 2031
7.10.3 Spain OTC Drug and Dietary Supplement Sales Value Share by Application, 2024 VS 2031
7.11 Russia
7.11.1 Russia OTC Drug and Dietary Supplement Sales Value Growth Rate (2020-2031)
7.11.2 Russia OTC Drug and Dietary Supplement Sales Value Share by Type, 2024 VS 2031
7.11.3 Russia OTC Drug and Dietary Supplement Sales Value Share by Application, 2024 VS 2031
7.12 Netherlands
7.12.1 Netherlands OTC Drug and Dietary Supplement Sales Value Growth Rate (2020-2031)
7.12.2 Netherlands OTC Drug and Dietary Supplement Sales Value Share by Type, 2024 VS 2031
7.12.3 Netherlands OTC Drug and Dietary Supplement Sales Value Share by Application, 2024 VS 2031
7.13 Nordic Countries
7.13.1 Nordic Countries OTC Drug and Dietary Supplement Sales Value Growth Rate (2020-2031)
7.13.2 Nordic Countries OTC Drug and Dietary Supplement Sales Value Share by Type, 2024 VS 2031
7.13.3 Nordic Countries OTC Drug and Dietary Supplement Sales Value Share by Application, 2024 VS 2031
7.14 China
7.14.1 China OTC Drug and Dietary Supplement Sales Value Growth Rate (2020-2031)
7.14.2 China OTC Drug and Dietary Supplement Sales Value Share by Type, 2024 VS 2031
7.14.3 China OTC Drug and Dietary Supplement Sales Value Share by Application, 2024 VS 2031
7.15 Japan
7.15.1 Japan OTC Drug and Dietary Supplement Sales Value Growth Rate (2020-2031)
7.15.2 Japan OTC Drug and Dietary Supplement Sales Value Share by Type, 2024 VS 2031
7.15.3 Japan OTC Drug and Dietary Supplement Sales Value Share by Application, 2024 VS 2031
7.16 South Korea
7.16.1 South Korea OTC Drug and Dietary Supplement Sales Value Growth Rate (2020-2031)
7.16.2 South Korea OTC Drug and Dietary Supplement Sales Value Share by Type, 2024 VS 2031
7.16.3 South Korea OTC Drug and Dietary Supplement Sales Value Share by Application, 2024 VS 2031
7.17 India
7.17.1 India OTC Drug and Dietary Supplement Sales Value Growth Rate (2020-2031)
7.17.2 India OTC Drug and Dietary Supplement Sales Value Share by Type, 2024 VS 2031
7.17.3 India OTC Drug and Dietary Supplement Sales Value Share by Application, 2024 VS 2031
7.18 Australia
7.18.1 Australia OTC Drug and Dietary Supplement Sales Value Growth Rate (2020-2031)
7.18.2 Australia OTC Drug and Dietary Supplement Sales Value Share by Type, 2024 VS 2031
7.18.3 Australia OTC Drug and Dietary Supplement Sales Value Share by Application, 2024 VS 2031
7.19 Southeast Asia
7.19.1 Southeast Asia OTC Drug and Dietary Supplement Sales Value Growth Rate (2020-2031)
7.19.2 Southeast Asia OTC Drug and Dietary Supplement Sales Value Share by Type, 2024 VS 2031
7.19.3 Southeast Asia OTC Drug and Dietary Supplement Sales Value Share by Application, 2024 VS 2031
7.20 Brazil
7.20.1 Brazil OTC Drug and Dietary Supplement Sales Value Growth Rate (2020-2031)
7.20.2 Brazil OTC Drug and Dietary Supplement Sales Value Share by Type, 2024 VS 2031
7.20.3 Brazil OTC Drug and Dietary Supplement Sales Value Share by Application, 2024 VS 2031
7.21 Argentina
7.21.1 Argentina OTC Drug and Dietary Supplement Sales Value Growth Rate (2020-2031)
7.21.2 Argentina OTC Drug and Dietary Supplement Sales Value Share by Type, 2024 VS 2031
7.21.3 Argentina OTC Drug and Dietary Supplement Sales Value Share by Application, 2024 VS 2031
7.22 Chile
7.22.1 Chile OTC Drug and Dietary Supplement Sales Value Growth Rate (2020-2031)
7.22.2 Chile OTC Drug and Dietary Supplement Sales Value Share by Type, 2024 VS 2031
7.22.3 Chile OTC Drug and Dietary Supplement Sales Value Share by Application, 2024 VS 2031
7.23 Colombia
7.23.1 Colombia OTC Drug and Dietary Supplement Sales Value Growth Rate (2020-2031)
7.23.2 Colombia OTC Drug and Dietary Supplement Sales Value Share by Type, 2024 VS 2031
7.23.3 Colombia OTC Drug and Dietary Supplement Sales Value Share by Application, 2024 VS 2031
7.24 Peru
7.24.1 Peru OTC Drug and Dietary Supplement Sales Value Growth Rate (2020-2031)
7.24.2 Peru OTC Drug and Dietary Supplement Sales Value Share by Type, 2024 VS 2031
7.24.3 Peru OTC Drug and Dietary Supplement Sales Value Share by Application, 2024 VS 2031
7.25 Saudi Arabia
7.25.1 Saudi Arabia OTC Drug and Dietary Supplement Sales Value Growth Rate (2020-2031)
7.25.2 Saudi Arabia OTC Drug and Dietary Supplement Sales Value Share by Type, 2024 VS 2031
7.25.3 Saudi Arabia OTC Drug and Dietary Supplement Sales Value Share by Application, 2024 VS 2031
7.26 Israel
7.26.1 Israel OTC Drug and Dietary Supplement Sales Value Growth Rate (2020-2031)
7.26.2 Israel OTC Drug and Dietary Supplement Sales Value Share by Type, 2024 VS 2031
7.26.3 Israel OTC Drug and Dietary Supplement Sales Value Share by Application, 2024 VS 2031
7.27 UAE
7.27.1 UAE OTC Drug and Dietary Supplement Sales Value Growth Rate (2020-2031)
7.27.2 UAE OTC Drug and Dietary Supplement Sales Value Share by Type, 2024 VS 2031
7.27.3 UAE OTC Drug and Dietary Supplement Sales Value Share by Application, 2024 VS 2031
7.28 Turkey
7.28.1 Turkey OTC Drug and Dietary Supplement Sales Value Growth Rate (2020-2031)
7.28.2 Turkey OTC Drug and Dietary Supplement Sales Value Share by Type, 2024 VS 2031
7.28.3 Turkey OTC Drug and Dietary Supplement Sales Value Share by Application, 2024 VS 2031
7.29 Iran
7.29.1 Iran OTC Drug and Dietary Supplement Sales Value Growth Rate (2020-2031)
7.29.2 Iran OTC Drug and Dietary Supplement Sales Value Share by Type, 2024 VS 2031
7.29.3 Iran OTC Drug and Dietary Supplement Sales Value Share by Application, 2024 VS 2031
7.30 Egypt
7.30.1 Egypt OTC Drug and Dietary Supplement Sales Value Growth Rate (2020-2031)
7.30.2 Egypt OTC Drug and Dietary Supplement Sales Value Share by Type, 2024 VS 2031
7.30.3 Egypt OTC Drug and Dietary Supplement Sales Value Share by Application, 2024 VS 2031
8 Company Profiles
8.1 Abbott
8.1.1 Abbott Comapny Information
8.1.2 Abbott Business Overview
8.1.3 Abbott OTC Drug and Dietary Supplement Revenue and Gross Margin (2020-2025)
8.1.4 Abbott OTC Drug and Dietary Supplement Product Portfolio
8.1.5 Abbott Recent Developments
8.2 Pfizer
8.2.1 Pfizer Comapny Information
8.2.2 Pfizer Business Overview
8.2.3 Pfizer OTC Drug and Dietary Supplement Revenue and Gross Margin (2020-2025)
8.2.4 Pfizer OTC Drug and Dietary Supplement Product Portfolio
8.2.5 Pfizer Recent Developments
8.3 GSK
8.3.1 GSK Comapny Information
8.3.2 GSK Business Overview
8.3.3 GSK OTC Drug and Dietary Supplement Revenue and Gross Margin (2020-2025)
8.3.4 GSK OTC Drug and Dietary Supplement Product Portfolio
8.3.5 GSK Recent Developments
8.4 Bayer
8.4.1 Bayer Comapny Information
8.4.2 Bayer Business Overview
8.4.3 Bayer OTC Drug and Dietary Supplement Revenue and Gross Margin (2020-2025)
8.4.4 Bayer OTC Drug and Dietary Supplement Product Portfolio
8.4.5 Bayer Recent Developments
8.5 Suntory
8.5.1 Suntory Comapny Information
8.5.2 Suntory Business Overview
8.5.3 Suntory OTC Drug and Dietary Supplement Revenue and Gross Margin (2020-2025)
8.5.4 Suntory OTC Drug and Dietary Supplement Product Portfolio
8.5.5 Suntory Recent Developments
8.6 Reckitt Benckiser
8.6.1 Reckitt Benckiser Comapny Information
8.6.2 Reckitt Benckiser Business Overview
8.6.3 Reckitt Benckiser OTC Drug and Dietary Supplement Revenue and Gross Margin (2020-2025)
8.6.4 Reckitt Benckiser OTC Drug and Dietary Supplement Product Portfolio
8.6.5 Reckitt Benckiser Recent Developments
8.7 Herbalife
8.7.1 Herbalife Comapny Information
8.7.2 Herbalife Business Overview
8.7.3 Herbalife OTC Drug and Dietary Supplement Revenue and Gross Margin (2020-2025)
8.7.4 Herbalife OTC Drug and Dietary Supplement Product Portfolio
8.7.5 Herbalife Recent Developments
8.8 Glanbia
8.8.1 Glanbia Comapny Information
8.8.2 Glanbia Business Overview
8.8.3 Glanbia OTC Drug and Dietary Supplement Revenue and Gross Margin (2020-2025)
8.8.4 Glanbia OTC Drug and Dietary Supplement Product Portfolio
8.8.5 Glanbia Recent Developments
8.9 Blackmores
8.9.1 Blackmores Comapny Information
8.9.2 Blackmores Business Overview
8.9.3 Blackmores OTC Drug and Dietary Supplement Revenue and Gross Margin (2020-2025)
8.9.4 Blackmores OTC Drug and Dietary Supplement Product Portfolio
8.9.5 Blackmores Recent Developments
8.10 Amway
8.10.1 Amway Comapny Information
8.10.2 Amway Business Overview
8.10.3 Amway OTC Drug and Dietary Supplement Revenue and Gross Margin (2020-2025)
8.10.4 Amway OTC Drug and Dietary Supplement Product Portfolio
8.10.5 Amway Recent Developments
9 Concluding Insights
10 Appendix
10.1 Reasons for Doing This Study
10.2 Research Methodology
10.3 Research Process
10.4 Authors List of This Report
10.5 Data Source
10.5.1 Secondary Sources
10.5.2 Primary Sources
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.